Consortium organization
The organizational structure of Lifelong VISION is designed to promote (i) transparent and collaborative decision-making at all levels, (ii) efficient progress monitoring and reporting, (ii) fruitful interactions with external experts and stakeholders, and (iv) optimal embedding at the participating institutes.
learn moreConsortium organization
The organizational structure of Lifelong VISION is designed to promote (i) transparent and collaborative decision-making at all levels, (ii) efficient progress monitoring and reporting, (ii) fruitful interactions with external experts and stakeholders, and (iv) optimal embedding at the participating institutes.
The organizational structure consists of the following Consortium Bodies:
- Executive Board
- Coordinator
- Project Support Office
Furthermore, the following advisory boards and councils shall exist:
- Scientific Advisory Board (SAB)
- Institutional Board (IB)
The people involved
The program is organized in pillars and platforms. Each of those has a page the team members:
- Pillar 1: Gene-based therapy
- Pillar 2: Pathway-based therapy
- Pillar 3: Cell-based therapy
- Platform A: Model systems
- Platform B: Patient profiling
For an overview of everyone involved please visit our team page.
Gene-based therapy Pillar 1
To design and refine truly personalized, innovative and effective treatments for visually impaired individuals.
read morePatient profiling Platform B
A datadriven approach to define intervention-specific disease signatures.
read more